Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer.

Front Oncol · 2022 · PMC9329611 · PMID 35912186

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a small trendP =0.10so close (0.05 < p ≤ 0.1)

Patients treated with concurrent and sequential dCRT also had similar PFS outcome ( P =0.56, Supplementary Figure 2A ), albeit a small trend towards increased OS in patients treated with concurrent dCRT (HR [95% CI] =0.63 [0.37-1.1], P =0.10, Supplementary Figure 2B ).

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.